AMG has extensive experience in deal structuring, licensing, and partnering as well as mergers and acquisitions. Our collective experience allows us to tap into an unparalleled network of medical device company executives, industry thought leaders, and clinicians.
AMG’s evaluation process includes a thorough market analysis containing financial models, budgeting and revenue projections. The process also addresses a market development plan that can be implemented with commercialization. All factors involved in determining the current market dynamics are considered, including incidence and prevalence
AMG’s evaluation process includes a thorough market analysis containing financial models, budgeting and revenue projections. The process also addresses a market development plan that can be implemented with commercialization. All factors involved in determining the current market dynamics are considered, including incidence and prevalence of the clinical need, competitive/predicate device cost, procedural cost, reimbursement issues, target physician, referral patterns, and competitive clinical solutions.
A significant aspect of developing a medical device for long-term success is insight from highly skilled and experienced physicians. AMG’s clinical network has extensive expertise in working on new product concepts. They have individually and collectively reshaped the medical device landscape over the last 20 years. The areas of expertise
A significant aspect of developing a medical device for long-term success is insight from highly skilled and experienced physicians. AMG’s clinical network has extensive expertise in working on new product concepts. They have individually and collectively reshaped the medical device landscape over the last 20 years. The areas of expertise range from Otolaryngology, Orthopedics, General Surgery, Breast Cancer, and Primary Care.
AMG assists each new product in establishing its own independent operations and infrastructure. Throughout the development and commercialization of the new product, AMG remains fully engaged, driving the progress efforts forward, during which a controlled transfer of responsibility occurs. Throughout this time, AMG offers a range of resources to help ensure the new product’s long-term success, including serving as active advisors.
From the inception of the new product, AMG is focused on key value creation milestones. The concept is advanced using its seed funding until a larger infusion of capital is appropriate. At that point, AMG will look to its strong relationships within industry and venture capital partners to provide the next round of funding for the new product. AMG funds their business through solid relationships with their industry partners and extensive network of venture and private equity capital firms. Our experience can help secure seed capital and prepare for larger venture capital financing by building and presenting a cohesive funding strategy.
AMG offers each new product direct market access via AMG’s own independent distribution operations and infrastructure. Throughout the United States and the rest of the world, AMG has built a tremendous network of focused distributors and sales representatives.